TNF and Cowden disease: Phase 3 GRAVITI Guselkumab efficacy and safety NCT05197049 [45].Phase 3 FUZION-CD Guselkumab in peri-anal CD NCT0534709 [46].Phase 2 trial DUET CD Combination with Golimumab (anti-TNF) NCT05242471 [47].